Alteration of the p14ARF gene and p53 status in human hepatocellular carcinomas

Journal of Gastroenterology

Volumn 39, Issue 4, 2004, Pages 355-361

  Ito, Teruaki ^a   Nishida, Naoshi ^a   Fukuda, Yoshihiro ^b   Nishimura, Takafumi ^a   Komeda, Toshiki ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; INK4a ARF locus; p14ARF; p53

Indexed keywords

MESSENGER RNA; PROTEIN P14ARF; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CARCINOGENICITY; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNOLOGY; EXON; FEMALE; FREQUENCY ANALYSIS; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, P53; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 2542423876     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1302-9     Document Type: Article

References (31)

1. Serrano M, Hunnon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature 1993;366:704-7.
2. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho R, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
3. Quella DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encodes two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83: 933-1000.
4. Cardas C, Hahn SA, Da Costa LT, Redston MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 gene in pancreatic adenocarcinoma. Nature Genetics 1994;8:27-32.
5. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MST1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
6. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
7. INK4a gene in liver cancer. Int J Cancer 1996;67:176-80.
8. K4a is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 1999; 116:394-400.
9. Azechi H, Nishida N, Fukuda Y, Nishimura T, Minata M, Katuma H, et al. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 2001;60:346-54.
10. Markl ID, Jones PA. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res 1998;58:5348-53.
11. Sanchez-Cepedes M, Reed AI, Buta M, Wu L, Westra WH, Herman JG, et al. Inactivation of the INK4a/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene 1999;18:5843-9.
12. Iwato M, Tachibana O, Tohma Y, Arakawa Y, Nitta H, Hasegawa M, et al. Alterations of the INK4a/ARF locus in human intracranial germ cell tumors. Cancer Res 2000;60:2113-5.
13. INK4a methylation and p53 mutational status. Cancer Res 2000;60:129-33.
14. ARF gene in gastric cancer. Int J Cancer 2000;87:654-8.
15. INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999;5:2704-13.
16. ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 over expression. Oncogene 1998;17:2779-85.
17. ARF expression in breast cancer. Oncogene 2001; 20: 4586-90.
18. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, et al. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in coloretal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 2000;21:2057-64.
19. ARF in hematological malignancies. Leukemia 1999;13:1760-9.
20. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenaga M, et al. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993;53:368-72.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd Ed. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989. p. 7.6-9.24.
22. Baek MJ, Piao Z, Kim NG, Park C, Shin EC, Park JH, et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000;89:60-8.
23. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
24. Peng C-Y, Chen T-C, Hung S-P, Chen M-F, Yeh C-T, Tsai S-L, et al. Genetic alterations of INK4a/ARF locus and p53 in human hepatocellular carcinoma. Anticancer Res 2002;22:1265-72.
25. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, et al. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 2001;20:7104-9.
26. ARF locus in Australian and South African hepatocellular carcinoma. J Gastroenterol Hepatol 2002; 17:301-7.
27. ARF tumor suppressor mediate nucleolar localization. Oncogene 2000;19:2978-85.
28. Zhang Y, Xing Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol ell 1999;3:579-91.
29. ARF. Oncogene 2001;20:5543-7.
30. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression. Cell 1998;92:725-34.
31. Karen H. p53: Death star. Cell 2000;103:691-4.